Ji Zeqi, Chen Lingzhi, Yang Qiuping, Tian Huiting, Wu Jinyao, Zheng Daitian, Cai Jiehui, Chen Yexi, Li Zhiyang
Department of Thyroid, Breast and Hernia Surgery, General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Front Oncol. 2023 Jan 13;12:1090503. doi: 10.3389/fonc.2022.1090503. eCollection 2022.
Recently, ctDNA has become the focus for scientists with respect to personalized treatment, early screening, precise diagnosis, and prognosis of BC. This paper aims to use bibliometric analysis to investigate the research status and future trends in this field.
All the related literature in the field of ctDNA and breast cancer was gathered from the Web of Science Core Collection. Data analyses were performed with R package Bibliometrics, VOS viewer 1.6.18, and online analysis in WoS. IBM SPSS (version 26.0) was used for statistical analysis.
A total of 739 publications, including 472 articles and 267 reviews, were retrieved. The overall number of articles published showed an upward trend. The United States has the largest number of published articles (266 papers) and citations (20,225 times). The most productive journal was Clinical Cancer Research. Cristofanilli M was the most prolific author, while Carlos C was the most cited one. The most frequent keywords excluding the search subject were "liquid biopsy", "plasma", "mutations", "metastatic breast cancer", "acquired resistance".
This article explored the application value of ctDNA in breast cancer with bibliometric analysis, offering an overall and intuitive understanding of this topic and revealing the study trends in the past ten years.
近年来,循环肿瘤DNA(ctDNA)已成为科学家们在乳腺癌个性化治疗、早期筛查、精准诊断和预后方面关注的焦点。本文旨在通过文献计量分析来研究该领域的研究现状和未来趋势。
从科学网核心合集收集了ctDNA与乳腺癌领域的所有相关文献。使用R包Bibliometrics、VOS viewer 1.6.18以及科学网的在线分析进行数据分析。使用IBM SPSS(版本26.0)进行统计分析。
共检索到739篇出版物,包括472篇文章和267篇综述。发表文章的总数呈上升趋势。美国发表的文章数量最多(266篇),被引次数最多(20225次)。发文量最多的期刊是《临床癌症研究》。克里斯托法尼利·M是发文量最多的作者,而卡洛斯·C是被引次数最多的作者。除搜索主题外,最频繁出现的关键词是“液体活检”“血浆”“突变”“转移性乳腺癌”“获得性耐药”。
本文通过文献计量分析探讨了ctDNA在乳腺癌中的应用价值,对该主题提供了全面直观的认识,并揭示了过去十年的研究趋势。